Arquivos Brasileiros de Cardiologia最新文献

英文中文

An Atypical Non-Cardiac Presentation of Hypertrophic Cardiomyopathy. 肥厚性心肌病的非典型非心脏表现。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20220933

André Alexandre, Carla Roque, Isabel Sá, João Silveira, Severo Torres

Supplementary Video 2) revealed moderate asymmetric septal LV hypertrophy (interventricular septum thickness 14 mm, posterior wall thickness 9 mm), mildly reduced LV ejection fraction (45%), apical akinesia, and an image suggestive of thrombus, explaining the cardioembolic stroke. Cardiovascular magnetic resonance (CMR) confirmed the diagnosis of HCM, with extensive apical fibrosis and akinesia of the apical segments, outlining an apical aneurysm and thrombus (Figure 2). Coronary angiography was performed regarding the possibility of concomitant ischemic heart disease, ruling out obstructive coronary artery disease. Serologic examination for Trypanosoma cruzi was negative. The patient was started on systemic anticoagulation with a vitamin K antagonist (VKA). Considering the diagnosis of HCM with extensive apical fibrosis and an apical aneurism, after patient-shared decision-making, it was decided to place a subcutaneous implantable cardioverter-defibrillator (S-ICD). He was discharged after 18 days. At the 1-year follow-up, control transthoracic echocardiography showed complete resolution of the apical thrombus, and the patient remained on systemic anticoagulation with a VKA. HCM is a relatively common but still underdiagnosed cardiac disease. 1 This case illustrates an extremely rare and life-threatening non-cardiac first presentation of HCM. This unusual HCM phenotype with a thin-walled, scarred LV apical aneurysm is associated with an increased risk of sudden arrhythmic death and thromboembolic stroke. 2,3

{"title":"An Atypical Non-Cardiac Presentation of Hypertrophic Cardiomyopathy.","authors":"André Alexandre, Carla Roque, Isabel Sá, João Silveira, Severo Torres","doi":"10.36660/abc.20220933","DOIUrl":"https://doi.org/10.36660/abc.20220933","url":null,"abstract":"Supplementary Video 2) revealed moderate asymmetric septal LV hypertrophy (interventricular septum thickness 14 mm, posterior wall thickness 9 mm), mildly reduced LV ejection fraction (45%), apical akinesia, and an image suggestive of thrombus, explaining the cardioembolic stroke. Cardiovascular magnetic resonance (CMR) confirmed the diagnosis of HCM, with extensive apical fibrosis and akinesia of the apical segments, outlining an apical aneurysm and thrombus (Figure 2). Coronary angiography was performed regarding the possibility of concomitant ischemic heart disease, ruling out obstructive coronary artery disease. Serologic examination for Trypanosoma cruzi was negative. The patient was started on systemic anticoagulation with a vitamin K antagonist (VKA). Considering the diagnosis of HCM with extensive apical fibrosis and an apical aneurism, after patient-shared decision-making, it was decided to place a subcutaneous implantable cardioverter-defibrillator (S-ICD). He was discharged after 18 days. At the 1-year follow-up, control transthoracic echocardiography showed complete resolution of the apical thrombus, and the patient remained on systemic anticoagulation with a VKA. HCM is a relatively common but still underdiagnosed cardiac disease. 1 This case illustrates an extremely rare and life-threatening non-cardiac first presentation of HCM. This unusual HCM phenotype with a thin-walled, scarred LV apical aneurysm is associated with an increased risk of sudden arrhythmic death and thromboembolic stroke. 2,3","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 6","pages":"e20220933"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10530233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Are We Reaching the End of the Evolutionary Road to Metallic Drug-Eluting Stents? Which 4th Generation Stents Do We Need? 金属药物洗脱支架的进化之路是否已经走到了尽头?我们需要哪种第四代支架?

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20230302

Manuel Sousa Almeida

Short Editorial related to the article: Real-World Assessment of an Ultrathin Strut, Sirolimus-Eluting Stent in Patients with ST-Elevation Myocardial Infarction Submitted to Primary Percutaneous Coronary Intervention (INSTEMI Registry)

引用次数: 0

Could Patients At Low Cardiovascular Risk Be Better Stratified? 低心血管风险患者是否可以更好地分层?

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20230310

Francisco Antonio Helfenstein Fonseca, Maria Cristina Izar

引用次数: 0

Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin. 构建并验证针对华法林口服抗凝药患者的方案。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20220576

Hannah Cardoso Barbosa, Heloisa de Carvalho Torres, João Antônio de Queiroz Oliveira, Rebeca Priscilla de Melo Santos, Josiane Moreira da Costa, Leonardo Gonçalves Miranda, Adriana Silvina Pagano, Marcus Fernando da Silva Praxedes, Maria Auxiliadora Parreiras Martins

Background: Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.

Objective: The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.

Methods: The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.

Results: Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.

Conclusion: EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.

背景：华法林是一种口服抗凝药，在预防血栓栓塞方面非常有用，但它被认为是一种极易引起不良反应的药物。考虑到控制口服抗凝药的实际困难，华法林患者可以从旨在改变行为、积极参与自我护理和坚持药物治疗的教育策略中获益：目的：构建并验证针对华法林患者行为改变的 EmpoderACO 方案：方法步骤包括：定义自我护理的概念和领域、确定目标、构建和选择项目、评估内容效度以及在目标人群中进行预测试：由一个多学科评委委员会（JC）通过 E-surv 网络平台对工具项目的相关性、适当性、清晰度和内部可靠性进行了评估，获得的平均一致性≥0.91。目标人群对该工具的理解程度显示出足够的清晰度，平均系数为 0.96：EmpoderACO 有助于改善医务人员与患者之间的沟通过程，提高患者对治疗和临床结果的依从性，可在医疗机构中推广使用。

{"title":"Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin.","authors":"Hannah Cardoso Barbosa, Heloisa de Carvalho Torres, João Antônio de Queiroz Oliveira, Rebeca Priscilla de Melo Santos, Josiane Moreira da Costa, Leonardo Gonçalves Miranda, Adriana Silvina Pagano, Marcus Fernando da Silva Praxedes, Maria Auxiliadora Parreiras Martins","doi":"10.36660/abc.20220576","DOIUrl":"10.36660/abc.20220576","url":null,"abstract":"Background: Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.Objective: The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.Methods: The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.Results: Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.Conclusion: EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 6","pages":"e20220576"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Incidence and Morphological Study of Myocardial Bridge in the State of Ceará: A Cadaveric Study. 心肌桥在心肌缺血状态下的发生率和形态学研究:一项尸体研究。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20220460

Jalles Dantas de Lucena, Hudson Martins de Brito, João Victor Souza Sanders, Jonathan Barros Cavalcante, Michelly Carneiro Collyer, Cecília de Lima Leite, Helson Freitas da Silveira, Julio Cesar Campos Ferreira Filho

Background: Myocardial bridges (MB) are anatomical anomalies with possible clinical repercussions; hence, their understanding deserves attention.

Objective: To determinate the prevalence and characterize MB in human hearts from the state of Ceará. Methods: Fifty hearts of adult human cadavers from the Medicine School of Federal University of Ceará, Brazil. The hearts were dissected to identify MBs that pass over part of the coronary artery. The segment of the artery (proximal, middle, and distal) with a bridge was identified. The external diameter of the artery at the proximal and distal points of the MB was measured. The length and thickness of the MB were also measured with an electronic caliper. The muscle index (MMI) of the MB was calculated as the product of length and thickness expressed in millimeters. The significance level adopted in the statistical analysis was 5%.

Results: MB was confirmed in 40% of sample. Approximately one third of the sample had only 1 MB. MB was most frequently found over the anterior interventricular branch of the left coronary artery (59.25%, p=0.02), and its prevalence in other branches was much lower (22.23%). The most affected segments of arteries were the superior (44.44%) and medium (40.74%). The mean diameter of arteries proximal to the MB was 2.38±0.97mm (range=0.78-5.15mm), and the diameter distal to the MB was 1.71±0.75mm (range=0.42-3.58mm). The length was measured as mean=8.55±5.27mm, while the mean thickness was 0.89±0.33mm.

Conclusion: A high prevalence of MB is more likely to affect the left coronary artery system with larger MMI than other affected branches.

背景:心肌桥(MB)是一种可能引起临床反应的解剖异常;因此，他们的理解值得关注。目的:了解心肌梗死患者心肌MB的患病率及特征。方法:取材于巴西塞埃尔联邦大学医学院成人尸体50具心脏。解剖心脏以确定通过部分冠状动脉的MBs。确定了带桥的动脉段(近、中、远)。测量MB近端和远端动脉外径。同时用电子卡尺测量MB的长度和厚度。MB的肌肉指数(muscle index, MMI)计算为长度与厚度的乘积，单位为毫米。统计学分析采用显著性水平5%。结果:40%的标本确诊为MB。大约三分之一的样本只有1 MB。MB最常见于左冠状动脉前室间支(59.25%，p=0.02)，其他分支的患病率要低得多(22.23%)。受影响最大的动脉段为上动脉(44.44%)和中动脉(40.74%)。动脉近端平均直径为2.38±0.97mm(范围0.78 ~ 5.15mm)，远端平均直径为1.71±0.75mm(范围0.42 ~ 3.58mm)。长度平均值为8.55±5.27mm，厚度平均值为0.89±0.33mm。结论:MMI较大的左冠状动脉系统比其他分支更易发生MB的高发。

{"title":"Incidence and Morphological Study of Myocardial Bridge in the State of Ceará: A Cadaveric Study.","authors":"Jalles Dantas de Lucena, Hudson Martins de Brito, João Victor Souza Sanders, Jonathan Barros Cavalcante, Michelly Carneiro Collyer, Cecília de Lima Leite, Helson Freitas da Silveira, Julio Cesar Campos Ferreira Filho","doi":"10.36660/abc.20220460","DOIUrl":"https://doi.org/10.36660/abc.20220460","url":null,"abstract":"Background: Myocardial bridges (MB) are anatomical anomalies with possible clinical repercussions; hence, their understanding deserves attention.Objective: To determinate the prevalence and characterize MB in human hearts from the state of Ceará. Methods: Fifty hearts of adult human cadavers from the Medicine School of Federal University of Ceará, Brazil. The hearts were dissected to identify MBs that pass over part of the coronary artery. The segment of the artery (proximal, middle, and distal) with a bridge was identified. The external diameter of the artery at the proximal and distal points of the MB was measured. The length and thickness of the MB were also measured with an electronic caliper. The muscle index (MMI) of the MB was calculated as the product of length and thickness expressed in millimeters. The significance level adopted in the statistical analysis was 5%.Results: MB was confirmed in 40% of sample. Approximately one third of the sample had only 1 MB. MB was most frequently found over the anterior interventricular branch of the left coronary artery (59.25%, p=0.02), and its prevalence in other branches was much lower (22.23%). The most affected segments of arteries were the superior (44.44%) and medium (40.74%). The mean diameter of arteries proximal to the MB was 2.38±0.97mm (range=0.78-5.15mm), and the diameter distal to the MB was 1.71±0.75mm (range=0.42-3.58mm). The length was measured as mean=8.55±5.27mm, while the mean thickness was 0.89±0.33mm.Conclusion: A high prevalence of MB is more likely to affect the left coronary artery system with larger MMI than other affected branches.","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 7","pages":"e20220460"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10548222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

New Technique for Preserving Cephalic Vein Flow in Pacemaker Implantation Ipsilateral to Arteriovenous Fistula. 动静脉瘘同侧起搏器植入中保留头静脉血流的新技术。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20220926

Mafalda Carrington, Pedro Silvério António, Natacha Rodrigues, Afonso Nunes-Ferreira, Ana Bernardes, Fausto J Pinto, João de Sousa, Pedro Marques

although there is not enough evidence to recommend device implantation contralateral to an arteriovenous fistula. 3 Small observational studies have demonstrated that arteriovenous fistula construction in patients with CIED may increase primary arteriovenous fistula failure on the same side, 8 and that there is a higher incidence of central venous stenosis in patients with ipsilateral CIED and arteriovenous fistula, comparing to patients with contralateral strategy. 9 In a retrospective cohort, 2 there were higher rates of central vein intervention in ipsilateral cases, even if the need for intervention in arteriovenous hemodialysis accesses were similar in both groups. In that study, ipsilateral cases corresponded more frequently to patients in which arteriovenous fistulas were constructed after CIED implantation (81%) and contralateral cases to patients with arteriovenous fistulas prior to CIED implantation (56%), thus suggesting that the maturity of the arteriovenous fistula may play an important role in the prevention of deep venous

{"title":"New Technique for Preserving Cephalic Vein Flow in Pacemaker Implantation Ipsilateral to Arteriovenous Fistula.","authors":"Mafalda Carrington, Pedro Silvério António, Natacha Rodrigues, Afonso Nunes-Ferreira, Ana Bernardes, Fausto J Pinto, João de Sousa, Pedro Marques","doi":"10.36660/abc.20220926","DOIUrl":"https://doi.org/10.36660/abc.20220926","url":null,"abstract":"although there is not enough evidence to recommend device implantation contralateral to an arteriovenous fistula. 3 Small observational studies have demonstrated that arteriovenous fistula construction in patients with CIED may increase primary arteriovenous fistula failure on the same side, 8 and that there is a higher incidence of central venous stenosis in patients with ipsilateral CIED and arteriovenous fistula, comparing to patients with contralateral strategy. 9 In a retrospective cohort, 2 there were higher rates of central vein intervention in ipsilateral cases, even if the need for intervention in arteriovenous hemodialysis accesses were similar in both groups. In that study, ipsilateral cases corresponded more frequently to patients in which arteriovenous fistulas were constructed after CIED implantation (81%) and contralateral cases to patients with arteriovenous fistulas prior to CIED implantation (56%), thus suggesting that the maturity of the arteriovenous fistula may play an important role in the prevention of deep venous","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 5","pages":"e20220926"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10051287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Carcinoid Heart Disease: A Case Report and Literature Review. 类癌性心脏病1例报告及文献复习。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20220245

Isabela Bispo Santos da Silva Costa, Edielle de Sant Anna Melo, Armando Furtado, Juliana Barbosa Sobral-Alves, Stephanie Itala Rizk, Luiz Alberto Benvenuti, Carlos E Rochitte, Carlos Manuel de Almeida Brandão, Pablo Maria Pomarentzeff, Cristina Salvadori Bittar, Filomena Regina Barbosa Gomes Galas, José Otavio Costa Auler Junior, Paulo Marcelo Gehm Hoff, Roberto Kalil Filho, Fabio Biscegli Jatene, Ludhmila Abrahão Hajjar

Isabela Bispo Santos da Silva Costa,1,2,3 Edielle de Sant`Anna Melo,1 Armando Furtado,2 Juliana Barbosa SobralAlves,1,2 Stephanie Itala Rizk,1,2 Luiz Alberto Benvenuti,2 Carlos E. Rochitte,2 Carlos Manuel de Almeida Brandão,2 Pablo Maria Pomarentzeff,2 Cristina Salvadori Bittar,1,2 Filomena Regina Barbosa Gomes Galas,2,3 José Otavio Costa Auler Junior,2 Paulo Marcelo Gehm Hoff,1 Roberto Kalil Filho,2,3 Fabio Biscegli Jatene,2 Ludhmila Abrahão Hajjar1,2 Universidade de São Paulo Instituto do Câncer do Estado de São Paulo,1 São Paulo, SP – Brasil Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo,2 São Paulo, SP – Brasil Hospital Sírio-Libanês,3 São Paulo, SP – Brasil

{"title":"Carcinoid Heart Disease: A Case Report and Literature Review.","authors":"Isabela Bispo Santos da Silva Costa, Edielle de Sant Anna Melo, Armando Furtado, Juliana Barbosa Sobral-Alves, Stephanie Itala Rizk, Luiz Alberto Benvenuti, Carlos E Rochitte, Carlos Manuel de Almeida Brandão, Pablo Maria Pomarentzeff, Cristina Salvadori Bittar, Filomena Regina Barbosa Gomes Galas, José Otavio Costa Auler Junior, Paulo Marcelo Gehm Hoff, Roberto Kalil Filho, Fabio Biscegli Jatene, Ludhmila Abrahão Hajjar","doi":"10.36660/abc.20220245","DOIUrl":"https://doi.org/10.36660/abc.20220245","url":null,"abstract":"Isabela Bispo Santos da Silva Costa,1,2,3 Edielle de Sant`Anna Melo,1 Armando Furtado,2 Juliana Barbosa SobralAlves,1,2 Stephanie Itala Rizk,1,2 Luiz Alberto Benvenuti,2 Carlos E. Rochitte,2 Carlos Manuel de Almeida Brandão,2 Pablo Maria Pomarentzeff,2 Cristina Salvadori Bittar,1,2 Filomena Regina Barbosa Gomes Galas,2,3 José Otavio Costa Auler Junior,2 Paulo Marcelo Gehm Hoff,1 Roberto Kalil Filho,2,3 Fabio Biscegli Jatene,2 Ludhmila Abrahão Hajjar1,2 Universidade de São Paulo Instituto do Câncer do Estado de São Paulo,1 São Paulo, SP – Brasil Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo,2 São Paulo, SP – Brasil Hospital Sírio-Libanês,3 São Paulo, SP – Brasil","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 6","pages":"e20220245"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10548215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Triglycerides-Glucose İndex and Coronary Slow Flow: A New Diagnostic Tool? 甘油三酯-葡萄糖İndex与冠状动脉慢血流:一种新的诊断工具?

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-06-01 DOI: 10.36660/abc.20230373

Maria Cristina Costa de Almeida, Marildes Luiza de Castro

引用次数: 0

Analysis of low-density lipoprotein in diabetic patients using the Martin/Hopkins and Sampson equationsReply. 用Martin/Hopkins和Sampson方程分析糖尿病患者的低密度脂蛋白[j]。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-05-26 DOI: 10.36660/abc.20220859

Cristian Rodrigues do Nascimento, Rodrigo Mendes, Carlos Alberto de Lima Botelho Filho, Romero Henrique de Almeida Barbosa, Pedro Pereira Tenório

引用次数: 0

Erratum. 勘误表。

IF 2.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia

Pub Date : 2023-05-26 DOI: 10.36660/abc.20230306

[This corrects the article doi: 10.36660/abc.20230203] [This corrects the article doi: 10.36660/abc.20220734].

[更正文章doi: 10.36660/abc]。[更正文章doi: 10.36660/abc.20220734]。

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Arquivos Brasileiros de Cardiologia

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀